$4.30
-0.45-9.47%
At close: -
$4.21
-0.09-2.09%
After Hours: 4:10 PM EDT
Comments
Loading...
Personalis (PSNL) Forecast
NewsEarningsPersonalis (PSNL) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestPersonalis (NASDAQ:PSNL) Stock Quotes, Forecast and News Summary
Personalis Stock (NASDAQ: PSNL) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Personalis (PSNL) stock?
You can purchase shares of Personalis (NASDAQ:PSNL) through any online brokerage.
Who are Personalis (PSNL) competitors?
Other companies in Personalis’s space includes: Harvard Bioscience (NASDAQ:HBIO), Codexis (NASDAQ:CDXS), Lifecore Biomedical (NASDAQ:LFCR), Quanterix (NASDAQ:QTRX) and Conduit Pharmaceuticals (NASDAQ:CDT).
What is the forecast, or price target, for Personalis (PSNL) stock?
Personalis has a consensus price target of $8.89.
What is the current price for Personalis (PSNL)?
The stock price for Personalis (NASDAQ: PSNL) is $4.21 last updated November 14, 2024 at 4:10 PM EST.
Does Personalis (PSNL) pay a dividend?
There are no upcoming dividends for Personalis.
When is Personalis (NASDAQ:PSNL) reporting earnings?
Personalis’s Q3 earnings are confirmed for Wednesday, November 6, 2024.
Is Personalis (PSNL) going to split?
There is no upcoming split for Personalis.
What sector and industry does Personalis (PSNL) operate in?
Personalis is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.